Clinical Trial Update: Phase 2 Study of the Safety and Efficacy of LDP-02 in Mildly to Moderately Active Crohn's Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LDP-02 for safety and efficacy in patients with mild-to-moderately active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• LDP-02

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED